etilevodopa 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
dopamine receptor agonists, dopamine derivatives, used as antiparkinsonism/prolactin inhibitors 4422 37178-37-3

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • etilevodopa
  • levodopa ethyl ester
is the ethyl ester of levodopa; an antiparkinson drug
  • Molecular weight: 225.24
  • Formula: C11H15NO4
  • CLOGP: 0.24
  • LIPINSKI: 0
  • HAC: 5
  • HDO: 3
  • TPSA: 92.78
  • ALOGS: -2.10
  • ROTB: 5

Drug dosage:

None

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

PropertyDescriptionValueUnitConfidenceSimilarity
kinase-safety-class ACVR2A,ACVR2B,ACVRL1,AKT2,AKT3,ALK,AURKA,AXL,BRAF,BTK,CAMK2B,CAMK2D,CDK2,CDK4,CDK5,CDK9,CSF1R,DDR1,DYRK1B,EGFR,EIF2AK3,EPHB4,ERBB2,FLT1,FLT3,GRK2,GRK3,GSK3B,IGF1R,ITK,JAK1,JAK2,JAK3,KDR,KIT,MAP2K6,MAP3K14,MAP3K21,MAP3K7,MAP4K1,MAPK1,MAPK10,MAPK12,MAPK14,MAPK7,MAPK8,MAPK9,MAPKAPK2,MARK4,MTOR,NTRK2,PDK1,PDK2,PDK4,PDPK1,PIK3CB,PIM2,PLK1,PRKCD,PRKDC,PTK2,SIK2,SIK3,STK33,SYK,TEK,TGFBR1,TTK,ULK1,ULK2,ZAP70 71
kinase-selectivity-class ACVR2B,AXL,BMX,BRAF,CDK9,DDR1,DYRK1B,EIF2AK3,EPHB4,GRK2,MAP2K6,MAP3K14,MAPK7,MAPK8,PRKDC,SIK2,STK33,SYK,TEK,TGFBR1 20
pfas-class PFAS structural alert (1 = True, 0 = False) 0

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC N04BA06 NERVOUS SYSTEM
ANTI-PARKINSON DRUGS
DOPAMINERGIC AGENTS
Dopa and dopa derivatives

Related Drugs by ATC class:

N04BA Dopa and dopa derivatives 3 drugs

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 9.52 acidic
pKa2 12.62 acidic
pKa3 7.1 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
D04097 KEGG_DRUG
C1434556 UMLSCUI
CHEBI:135971 CHEBI
CHEMBL1823681 ChEMBL_ID
DB06535 DRUGBANK_ID
C481190 MESH_SUPPLEMENTAL_RECORD_UI
C454359 MESH_SUPPLEMENTAL_RECORD_UI
7818 INN_ID
895X917GYE UNII
170345 PUBCHEM_CID
1421444 RXNORM
895X917GYE INXIGHT DRUGS

Pharmaceutical products:

None